Free Trial
NYSE:NNVC

NanoViricides (NNVC) Stock Price, News & Analysis

$2.20
+0.08 (+3.77%)
(As of 05/21/2024 ET)
Today's Range
$2.07
$2.23
50-Day Range
$1.10
$2.25
52-Week Range
$1.00
$2.29
Volume
223,804 shs
Average Volume
84,226 shs
Market Capitalization
$25.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NNVC stock logo

About NanoViricides Stock (NYSE:NNVC)

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company's product portfolio includes NV-CoV-2, nanoviricide drug which is in phase 1a/1b clinical trails for the treatment of Covid; and NV-CoV-2 Oral Syrup, and NV-CoV-2 Oral Gummies, a semi-solid fixed-dose form which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric cases. It also offers NV-CoV-2 Solution for injection, infusion, and inhalation to treat severe cases that are not yet hospitalized would be best performed by an injection; and injectable solution can be delivered directly into the lungs as a fog created using standard portable battery operated nebulizer devices which enables action at the most important site of infection by a respiratory virus, such as coronaviruses, RSV, influenzas, human meta-pneumovirus, certain adenoviruses, and other infections, that can lead to severe pneumonia. In addition, the company provides Nanoviricide, a biomimetic platform technology designed to attack enveloped virus particles to deliver anti-viral payload into infected cells sparing uninfected cells to block replication cycle without toxicity. NanoViricides, Inc. was incorporated in 2005 and is headquartered in Shelton, Connecticut.

NNVC Stock Price History

NNVC Stock News Headlines

NanoViricides, Inc. (NNVC)
NanoViricides completes Phase 1 trial of lead asset NV-387
NanoViricides successfully concludes first-in-human study
See More Headlines
Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
5/21/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-8,590,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.28 per share

Miscellaneous

Free Float
11,271,000
Market Cap
$25.75 million
Optionable
Optionable
Beta
0.70
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Anil R. Diwan Ph.D. (Age 65)
    Executive Chairman, President, CEO & Secretary
    Comp: $400k
  • Ms. Meeta R. Vyas B.S. (Age 65)
    M.B.A., SB, MBA, Chief Financial Officer
    Comp: $129.6k
  • Dr. Randall W. Barton Ph.D. (Age 77)
    Chief Scientific Officer

NNVC Stock Analysis - Frequently Asked Questions

How have NNVC shares performed in 2024?

NanoViricides' stock was trading at $1.02 at the start of the year. Since then, NNVC stock has increased by 115.7% and is now trading at $2.20.
View the best growth stocks for 2024 here
.

How were NanoViricides' earnings last quarter?

NanoViricides, Inc. (NYSE:NNVC) issued its quarterly earnings data on Wednesday, May, 15th. The company reported ($0.16) earnings per share for the quarter.

When did NanoViricides' stock split?

Shares of NanoViricides reverse split on the morning of Tuesday, September 24th 2019. The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of NanoViricides?

Shares of NNVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NNVC) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners